Data set on Lassa fever in post-conflict Sierra Leone
Jeffrey G. Shaffer,
John S. Schieffelin,
Donald S. Grant,
Augustine Goba,
Mambu Momoh,
Lansana Kanneh,
Danielle C. Levy,
Jessica N. Hartnett,
Matt L. Boisen,
Luis M. Branco,
Robert F. Garry
Affiliations
Jeffrey G. Shaffer
Department of Global Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States; Corresponding author.
John S. Schieffelin
Departments of Pediatrics and Internal Medicine, Sections of Pediatric and Adult Infectious Diseases, Tulane University School of Medicine, New Orleans, LA, United States
Donald S. Grant
Viral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone; Ministry of Health and Sanitation, Freetown, Sierra Leone
Augustine Goba
Viral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone; Ministry of Health and Sanitation, Freetown, Sierra Leone
Mambu Momoh
Viral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone; Ministry of Health and Sanitation, Freetown, Sierra Leone
Lansana Kanneh
Viral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone; Ministry of Health and Sanitation, Freetown, Sierra Leone
Danielle C. Levy
Department of Microbiology and Immunology, Tulane University, New Orleans, LA, United States
Jessica N. Hartnett
Department of Microbiology and Immunology, Tulane University, New Orleans, LA, United States
Matt L. Boisen
Zalgen Labs, LLC, Germantown, MD, United States
Luis M. Branco
Zalgen Labs, LLC, Germantown, MD, United States
Robert F. Garry
Department of Microbiology and Immunology, Tulane University, New Orleans, LA, United States; Zalgen Labs, LLC, Germantown, MD, United States
Lassa fever is a rodent-borne illness that is endemic to parts of sub-Saharan Africa, including Sierra Leone, Nigeria, and Guinea. The disease is named after the town of Lassa, Nigeria where it was discovered in 1969. This data article focuses on the epidemiology of Lassa fever in Sierra Leone following a decade-long civil war that ended in 2002. The data were collected at Kenema Government Hospital (KGH) in Kenema, Sierra Leone, which maintains the country׳s only Lassa fever treatment facility and a biosafety level 3 (BSL-3) laboratory. The key data set variables include Lassa fever serostatus determined using antigen (Ag), immunoglobulin M (IgM), and immunoglobulin G (IgG) ELISA diagnostic techniques; and patient demographics, survival outcome, and treatment (ribavirin) status. The individual data used to generate the graphs and tables in the corresponding research manuscript published in PLOS Neglected Tropical Diseases in 2014 and its coding guide are provided as Supplementary material (Shaffer et al., 2014) [1]. Keywords: Infectious disease, Lassa fever, Epidemiology, Enzyme-linked immunosorbent assay (ELISA), Sierra Leone
